2m 2m 2m 2m 2m 2m 2m
CEL-SCI (CVM)
NYSE
$1.44+$0.02 (+1.20%)
Price as of Aug 21, 2026 7:57 PM EDT- $25.0MMarket Cap
- -85.08%1-Year Change
- BiotechnologyIndustry
CEL-SCI (CVM)
$1.44+$0.02 (+1.20%)
CVM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.42 | ||
Change | -$0.04 (-2.74%) | ||
Open | $1.48 | ||
High | $1.49 | ||
Low | $1.42 | ||
Previous Close | $1.46 | ||
Volume | 66,143 | ||
30-Day Average Volume | 204,304 | ||
1-Week Change | -7.79% | ||
1-Month Change | 13.60% | ||
1-Year Change | -85.08% | ||
3-Year Change | -96.62% | ||
5-Year Change | -99.50% | ||
Fundamentals | |||
Shares Outstanding | 17.6M | ||
Total Assets | $21.4M | ||
Market Cap | $25.0M | ||
Enterprise Value | $18.4M | ||
Period: QTR TTM FY | |||
Revenue | -$110,240.00 | ||
Net Income | -$5.7M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$5.6M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $2.4M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | -167 | ||
P/B | 2 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 05/20/2025 | ||
Earnings & Revenue